Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 14.1B | 13.3B | 13.2B | 13.3B |
Cost of revenue | 2.7B | 2.6B | 2.8B | 2.5B |
Gross profit | 11.3B | 10.7B | 10.4B | 10.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.5B | 1.3B | 1.3B | 1.6B |
Other operating expenses | — | — | — | — |
Operating income | 9.4B | 8.9B | 8.7B | 8.8B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 54.0M | 218.6M | 251.8M | 243.5M |
Other income expense | -581.1M | -1.2B | 143.9M | 261.5M |
Pretax income | 8.8B | 7.5B | 8.6B | 8.8B |
Tax provision | 1.5B | 1.2B | 1.5B | 1.5B |
Net income | 7.3B | 6.3B | 7.1B | 7.4B |
Basic EPS | 0.2 | 0.2 | 0.2 | 0.2 |
Diluted EPS | 0.2 | 0.2 | 0.2 | 0.2 |
Basic average shares | 34.1B | 34.3B | 34.5B | 34.1B |
Diluted average shares | 39.0B | 39.3B | 39.6B | 39.9B |
EBITDA | 9.8B | 9.3B | 9.1B | 9.2B |
Net income from continuing op. | 7.3B | 6.3B | 7.1B | 7.4B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |